Combating Illicit Xylazine Act (H.R. 1266)
February 12, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This bill changes the legal status of xylazine to a controlled substance, which will impose new registration, inventory, and security requirements on veterinarians, pharmacies, and manufacturers within 60 days to one year of enactment.
Potentially affected actors named in the source documents. Mention is not a position.
Veterinarians
Must comply with new registration, inventory, and recordkeeping requirements for xylazine within 60 days of enactment.
Xylazine Manufacturers
Must comply with new labeling and distribution requirements within one year, though they are exempt from specific capital expenditures for security upgrades.
Pet Owners
May continue to possess xylazine for animal care provided it is obtained through authorized veterinary channels.
Current stage: in_committee.
Floor Vote.
Summary
Why It Matters
This bill changes the legal status of xylazine to a controlled substance, which will impose new registration, inventory, and security requirements on veterinarians, pharmacies, and manufacturers within 60 days to one year of enactment.
Key Facts
- Classifies xylazine and its salts/isomers as a Schedule III controlled substance.
- Limits the 'ultimate user' of non-FDA approved xylazine to those obtaining it via a veterinarian or pharmacy for animal care, government animal-control, or wildlife programs.
- Manufacturers are exempt from capital expenditures for new security standards required by Schedule III status.
- Labeling, packaging, and distribution requirements for xylazine take effect one year after enactment.
- Practitioner registration, inventory, and recordkeeping requirements take effect 60 days after enactment.
- Practitioners applying for registration within the 60-day window may continue operations until the application is decided.
- Adds xylazine to the Automation of Reports and Consolidated Orders System (ARCOS) tracking requirements.
- Directs the U.S. Sentencing Commission to review and potentially amend sentencing guidelines for xylazine-related offenses.
- Requires the Attorney General to submit a report to Congress on illicit xylazine use within 18 months of enactment.
- Requires a follow-up report to Congress on xylazine prevalence four years after enactment.
- Clarifies that 'ultimate users' (animal owners/caregivers) do not need to register under the Controlled Substances Act to possess xylazine.
Frequently Asked Questions
Will veterinarians still be able to use xylazine?
Do I need to register with the DEA to possess xylazine for my pet?
When do the new recordkeeping rules for veterinarians start?
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Veterinary Exemption Focus
The bill goes to significant lengths to define 'ultimate user' specifically to protect the legality of veterinary and animal-control use, suggesting a legislative intent to avoid disrupting animal medical care while restricting human illicit use.
Connected Entities
Analysis Score
0–100- Significance85How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz50Current news / social attention level
Publisher tools